nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—UGT1A1—Etoposide—uterine cancer	0.26	0.334	CbGbCtD
Indacaterol—ABCB1—Progesterone—uterine cancer	0.115	0.148	CbGbCtD
Indacaterol—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.104	0.134	CbGbCtD
Indacaterol—ABCB1—Dactinomycin—uterine cancer	0.0914	0.117	CbGbCtD
Indacaterol—CYP3A4—Progesterone—uterine cancer	0.069	0.0887	CbGbCtD
Indacaterol—ABCB1—Etoposide—uterine cancer	0.0516	0.0662	CbGbCtD
Indacaterol—ABCB1—Doxorubicin—uterine cancer	0.0352	0.0452	CbGbCtD
Indacaterol—CYP3A4—Etoposide—uterine cancer	0.0309	0.0397	CbGbCtD
Indacaterol—CYP3A4—Doxorubicin—uterine cancer	0.0211	0.0271	CbGbCtD
Indacaterol—Exacerbation of asthma—Progesterone—uterine cancer	0.0153	0.0691	CcSEcCtD
Indacaterol—Musculoskeletal pain—Progesterone—uterine cancer	0.00404	0.0183	CcSEcCtD
Indacaterol—Musculoskeletal pain—Medroxyprogesterone Acetate—uterine cancer	0.00366	0.0166	CcSEcCtD
Indacaterol—Diabetes mellitus—Medroxyprogesterone Acetate—uterine cancer	0.00302	0.0136	CcSEcCtD
Indacaterol—Infection—Carboplatin—uterine cancer	0.0027	0.0122	CcSEcCtD
Indacaterol—Nasopharyngitis—Progesterone—uterine cancer	0.00259	0.0117	CcSEcCtD
Indacaterol—Asthma—Progesterone—uterine cancer	0.00251	0.0113	CcSEcCtD
Indacaterol—Angina pectoris—Progesterone—uterine cancer	0.00244	0.011	CcSEcCtD
Indacaterol—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.00239	0.0108	CcSEcCtD
Indacaterol—Nasopharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.00235	0.0106	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Progesterone—uterine cancer	0.00233	0.0105	CcSEcCtD
Indacaterol—Chest discomfort—Etoposide—uterine cancer	0.00231	0.0104	CcSEcCtD
Indacaterol—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.00227	0.0103	CcSEcCtD
Indacaterol—Hyperglycaemia—Progesterone—uterine cancer	0.00226	0.0102	CcSEcCtD
Indacaterol—Pneumonia—Progesterone—uterine cancer	0.00225	0.0102	CcSEcCtD
Indacaterol—Infestation—Progesterone—uterine cancer	0.00223	0.0101	CcSEcCtD
Indacaterol—Infestation NOS—Progesterone—uterine cancer	0.00223	0.0101	CcSEcCtD
Indacaterol—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.00223	0.0101	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00211	0.00954	CcSEcCtD
Indacaterol—Sinusitis—Progesterone—uterine cancer	0.0021	0.00947	CcSEcCtD
Indacaterol—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00205	0.00926	CcSEcCtD
Indacaterol—Infestation NOS—Medroxyprogesterone Acetate—uterine cancer	0.00203	0.00915	CcSEcCtD
Indacaterol—Infestation—Medroxyprogesterone Acetate—uterine cancer	0.00203	0.00915	CcSEcCtD
Indacaterol—Oedema peripheral—Progesterone—uterine cancer	0.00198	0.00893	CcSEcCtD
Indacaterol—Connective tissue disorder—Progesterone—uterine cancer	0.00197	0.00891	CcSEcCtD
Indacaterol—Sinusitis—Medroxyprogesterone Acetate—uterine cancer	0.0019	0.00858	CcSEcCtD
Indacaterol—Cardiac disorder—Progesterone—uterine cancer	0.00186	0.00841	CcSEcCtD
Indacaterol—Immune system disorder—Progesterone—uterine cancer	0.00181	0.00819	CcSEcCtD
Indacaterol—Mediastinal disorder—Progesterone—uterine cancer	0.00181	0.00817	CcSEcCtD
Indacaterol—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00809	CcSEcCtD
Indacaterol—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00807	CcSEcCtD
Indacaterol—Malnutrition—Progesterone—uterine cancer	0.00175	0.00789	CcSEcCtD
Indacaterol—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.00762	CcSEcCtD
Indacaterol—Muscle spasms—Progesterone—uterine cancer	0.00168	0.00758	CcSEcCtD
Indacaterol—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.00742	CcSEcCtD
Indacaterol—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.0074	CcSEcCtD
Indacaterol—Tremor—Progesterone—uterine cancer	0.00164	0.00739	CcSEcCtD
Indacaterol—Anaemia—Progesterone—uterine cancer	0.00161	0.00729	CcSEcCtD
Indacaterol—Pneumonia—Dactinomycin—uterine cancer	0.00159	0.00718	CcSEcCtD
Indacaterol—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00158	0.00715	CcSEcCtD
Indacaterol—Vertigo—Progesterone—uterine cancer	0.00157	0.00709	CcSEcCtD
Indacaterol—Palpitations—Progesterone—uterine cancer	0.00154	0.00697	CcSEcCtD
Indacaterol—Cough—Progesterone—uterine cancer	0.00152	0.00688	CcSEcCtD
Indacaterol—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00687	CcSEcCtD
Indacaterol—Chest pain—Progesterone—uterine cancer	0.00149	0.00672	CcSEcCtD
Indacaterol—Myalgia—Progesterone—uterine cancer	0.00149	0.00672	CcSEcCtD
Indacaterol—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.0067	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00148	0.00667	CcSEcCtD
Indacaterol—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00661	CcSEcCtD
Indacaterol—Dry mouth—Progesterone—uterine cancer	0.00145	0.00657	CcSEcCtD
Indacaterol—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00642	CcSEcCtD
Indacaterol—Infection—Progesterone—uterine cancer	0.00142	0.0064	CcSEcCtD
Indacaterol—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00632	CcSEcCtD
Indacaterol—Nervous system disorder—Progesterone—uterine cancer	0.0014	0.00631	CcSEcCtD
Indacaterol—Tachycardia—Progesterone—uterine cancer	0.00139	0.00628	CcSEcCtD
Indacaterol—Skin disorder—Progesterone—uterine cancer	0.00138	0.00625	CcSEcCtD
Indacaterol—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00609	CcSEcCtD
Indacaterol—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00609	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00604	CcSEcCtD
Indacaterol—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.00595	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Progesterone—uterine cancer	0.0013	0.00587	CcSEcCtD
Indacaterol—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.0058	CcSEcCtD
Indacaterol—Paraesthesia—Progesterone—uterine cancer	0.00128	0.00578	CcSEcCtD
Indacaterol—Dyspnoea—Progesterone—uterine cancer	0.00127	0.00574	CcSEcCtD
Indacaterol—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00572	CcSEcCtD
Indacaterol—Bronchospasm—Etoposide—uterine cancer	0.00126	0.0057	CcSEcCtD
Indacaterol—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00569	CcSEcCtD
Indacaterol—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00567	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Progesterone—uterine cancer	0.00123	0.00556	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00532	CcSEcCtD
Indacaterol—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00524	CcSEcCtD
Indacaterol—Musculoskeletal pain—Epirubicin—uterine cancer	0.00116	0.00524	CcSEcCtD
Indacaterol—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.0052	CcSEcCtD
Indacaterol—Pneumonia—Etoposide—uterine cancer	0.00115	0.00519	CcSEcCtD
Indacaterol—Infestation NOS—Etoposide—uterine cancer	0.00114	0.00516	CcSEcCtD
Indacaterol—Infestation—Etoposide—uterine cancer	0.00114	0.00516	CcSEcCtD
Indacaterol—Anaemia—Dactinomycin—uterine cancer	0.00114	0.00515	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00504	CcSEcCtD
Indacaterol—Musculoskeletal pain—Doxorubicin—uterine cancer	0.00107	0.00485	CcSEcCtD
Indacaterol—Myalgia—Dactinomycin—uterine cancer	0.00105	0.00475	CcSEcCtD
Indacaterol—Hypersensitivity—Progesterone—uterine cancer	0.00105	0.00474	CcSEcCtD
Indacaterol—Pruritus—Progesterone—uterine cancer	0.00101	0.00456	CcSEcCtD
Indacaterol—Infection—Dactinomycin—uterine cancer	0.001	0.00452	CcSEcCtD
Indacaterol—Diabetes mellitus—Epirubicin—uterine cancer	0.000956	0.00432	CcSEcCtD
Indacaterol—Cardiac disorder—Etoposide—uterine cancer	0.000953	0.0043	CcSEcCtD
Indacaterol—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000952	0.0043	CcSEcCtD
Indacaterol—Dizziness—Progesterone—uterine cancer	0.000943	0.00426	CcSEcCtD
Indacaterol—Immune system disorder—Etoposide—uterine cancer	0.000927	0.00419	CcSEcCtD
Indacaterol—Mediastinal disorder—Etoposide—uterine cancer	0.000925	0.00418	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000918	0.00415	CcSEcCtD
Indacaterol—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000914	0.00413	CcSEcCtD
Indacaterol—Rash—Progesterone—uterine cancer	0.000899	0.00406	CcSEcCtD
Indacaterol—Dermatitis—Progesterone—uterine cancer	0.000898	0.00406	CcSEcCtD
Indacaterol—Headache—Progesterone—uterine cancer	0.000893	0.00403	CcSEcCtD
Indacaterol—Diabetes mellitus—Doxorubicin—uterine cancer	0.000885	0.004	CcSEcCtD
Indacaterol—Muscle spasms—Etoposide—uterine cancer	0.000859	0.00388	CcSEcCtD
Indacaterol—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000854	0.00386	CcSEcCtD
Indacaterol—Nausea—Progesterone—uterine cancer	0.000847	0.00382	CcSEcCtD
Indacaterol—Anaemia—Etoposide—uterine cancer	0.000826	0.00373	CcSEcCtD
Indacaterol—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000814	0.00368	CcSEcCtD
Indacaterol—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000814	0.00368	CcSEcCtD
Indacaterol—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000809	0.00366	CcSEcCtD
Indacaterol—Vertigo—Etoposide—uterine cancer	0.000803	0.00363	CcSEcCtD
Indacaterol—Cough—Etoposide—uterine cancer	0.00078	0.00352	CcSEcCtD
Indacaterol—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000767	0.00347	CcSEcCtD
Indacaterol—Chest pain—Etoposide—uterine cancer	0.000761	0.00344	CcSEcCtD
Indacaterol—Hypokalaemia—Epirubicin—uterine cancer	0.000757	0.00342	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000755	0.00341	CcSEcCtD
Indacaterol—Nasopharyngitis—Epirubicin—uterine cancer	0.000744	0.00336	CcSEcCtD
Indacaterol—Hypersensitivity—Dactinomycin—uterine cancer	0.000742	0.00335	CcSEcCtD
Indacaterol—Infection—Etoposide—uterine cancer	0.000724	0.00327	CcSEcCtD
Indacaterol—Asthma—Epirubicin—uterine cancer	0.000719	0.00325	CcSEcCtD
Indacaterol—Tachycardia—Etoposide—uterine cancer	0.000712	0.00321	CcSEcCtD
Indacaterol—Skin disorder—Etoposide—uterine cancer	0.000708	0.0032	CcSEcCtD
Indacaterol—Hypokalaemia—Doxorubicin—uterine cancer	0.0007	0.00316	CcSEcCtD
Indacaterol—Angina pectoris—Epirubicin—uterine cancer	0.0007	0.00316	CcSEcCtD
Indacaterol—Nasopharyngitis—Doxorubicin—uterine cancer	0.000688	0.00311	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000668	0.00302	CcSEcCtD
Indacaterol—Asthma—Doxorubicin—uterine cancer	0.000665	0.003	CcSEcCtD
Indacaterol—Paraesthesia—Etoposide—uterine cancer	0.000655	0.00296	CcSEcCtD
Indacaterol—Dyspnoea—Etoposide—uterine cancer	0.00065	0.00294	CcSEcCtD
Indacaterol—Hyperglycaemia—Epirubicin—uterine cancer	0.000648	0.00293	CcSEcCtD
Indacaterol—Angina pectoris—Doxorubicin—uterine cancer	0.000648	0.00293	CcSEcCtD
Indacaterol—Pneumonia—Epirubicin—uterine cancer	0.000645	0.00291	CcSEcCtD
Indacaterol—Infestation NOS—Epirubicin—uterine cancer	0.000641	0.00289	CcSEcCtD
Indacaterol—Infestation—Epirubicin—uterine cancer	0.000641	0.00289	CcSEcCtD
Indacaterol—Rash—Dactinomycin—uterine cancer	0.000635	0.00287	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Etoposide—uterine cancer	0.00063	0.00284	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000618	0.00279	CcSEcCtD
Indacaterol—Sinusitis—Epirubicin—uterine cancer	0.000601	0.00272	CcSEcCtD
Indacaterol—Hyperglycaemia—Doxorubicin—uterine cancer	0.0006	0.00271	CcSEcCtD
Indacaterol—Nausea—Dactinomycin—uterine cancer	0.000598	0.0027	CcSEcCtD
Indacaterol—Pneumonia—Doxorubicin—uterine cancer	0.000596	0.00269	CcSEcCtD
Indacaterol—Infestation—Doxorubicin—uterine cancer	0.000593	0.00268	CcSEcCtD
Indacaterol—Infestation NOS—Doxorubicin—uterine cancer	0.000593	0.00268	CcSEcCtD
Indacaterol—Oedema peripheral—Epirubicin—uterine cancer	0.000567	0.00256	CcSEcCtD
Indacaterol—Connective tissue disorder—Epirubicin—uterine cancer	0.000565	0.00255	CcSEcCtD
Indacaterol—Sinusitis—Doxorubicin—uterine cancer	0.000556	0.00251	CcSEcCtD
Indacaterol—Hypersensitivity—Etoposide—uterine cancer	0.000537	0.00243	CcSEcCtD
Indacaterol—Cardiac disorder—Epirubicin—uterine cancer	0.000534	0.00241	CcSEcCtD
Indacaterol—Oedema peripheral—Doxorubicin—uterine cancer	0.000524	0.00237	CcSEcCtD
Indacaterol—Connective tissue disorder—Doxorubicin—uterine cancer	0.000523	0.00236	CcSEcCtD
Indacaterol—Immune system disorder—Epirubicin—uterine cancer	0.00052	0.00235	CcSEcCtD
Indacaterol—Mediastinal disorder—Epirubicin—uterine cancer	0.000518	0.00234	CcSEcCtD
Indacaterol—Pruritus—Etoposide—uterine cancer	0.000516	0.00233	CcSEcCtD
Indacaterol—Malnutrition—Epirubicin—uterine cancer	0.000501	0.00226	CcSEcCtD
Indacaterol—Cardiac disorder—Doxorubicin—uterine cancer	0.000494	0.00223	CcSEcCtD
Indacaterol—Dizziness—Etoposide—uterine cancer	0.000482	0.00218	CcSEcCtD
Indacaterol—Muscle spasms—Epirubicin—uterine cancer	0.000481	0.00217	CcSEcCtD
Indacaterol—Immune system disorder—Doxorubicin—uterine cancer	0.000481	0.00217	CcSEcCtD
Indacaterol—Mediastinal disorder—Doxorubicin—uterine cancer	0.00048	0.00217	CcSEcCtD
Indacaterol—Malnutrition—Doxorubicin—uterine cancer	0.000463	0.00209	CcSEcCtD
Indacaterol—Anaemia—Epirubicin—uterine cancer	0.000463	0.00209	CcSEcCtD
Indacaterol—Rash—Etoposide—uterine cancer	0.00046	0.00208	CcSEcCtD
Indacaterol—Dermatitis—Etoposide—uterine cancer	0.000459	0.00207	CcSEcCtD
Indacaterol—Headache—Etoposide—uterine cancer	0.000457	0.00206	CcSEcCtD
Indacaterol—Vertigo—Epirubicin—uterine cancer	0.00045	0.00203	CcSEcCtD
Indacaterol—Muscle spasms—Doxorubicin—uterine cancer	0.000446	0.00201	CcSEcCtD
Indacaterol—Palpitations—Epirubicin—uterine cancer	0.000443	0.002	CcSEcCtD
Indacaterol—Cough—Epirubicin—uterine cancer	0.000437	0.00197	CcSEcCtD
Indacaterol—Nausea—Etoposide—uterine cancer	0.000433	0.00196	CcSEcCtD
Indacaterol—Anaemia—Doxorubicin—uterine cancer	0.000428	0.00193	CcSEcCtD
Indacaterol—Chest pain—Epirubicin—uterine cancer	0.000426	0.00193	CcSEcCtD
Indacaterol—Myalgia—Epirubicin—uterine cancer	0.000426	0.00193	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000423	0.00191	CcSEcCtD
Indacaterol—Dry mouth—Epirubicin—uterine cancer	0.000417	0.00188	CcSEcCtD
Indacaterol—Vertigo—Doxorubicin—uterine cancer	0.000416	0.00188	CcSEcCtD
Indacaterol—Palpitations—Doxorubicin—uterine cancer	0.00041	0.00185	CcSEcCtD
Indacaterol—Infection—Epirubicin—uterine cancer	0.000406	0.00183	CcSEcCtD
Indacaterol—Cough—Doxorubicin—uterine cancer	0.000404	0.00183	CcSEcCtD
Indacaterol—Nervous system disorder—Epirubicin—uterine cancer	0.000401	0.00181	CcSEcCtD
Indacaterol—Tachycardia—Epirubicin—uterine cancer	0.000399	0.0018	CcSEcCtD
Indacaterol—Skin disorder—Epirubicin—uterine cancer	0.000397	0.00179	CcSEcCtD
Indacaterol—Myalgia—Doxorubicin—uterine cancer	0.000395	0.00178	CcSEcCtD
Indacaterol—Chest pain—Doxorubicin—uterine cancer	0.000395	0.00178	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000392	0.00177	CcSEcCtD
Indacaterol—Dry mouth—Doxorubicin—uterine cancer	0.000386	0.00174	CcSEcCtD
Indacaterol—Infection—Doxorubicin—uterine cancer	0.000376	0.0017	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000372	0.00168	CcSEcCtD
Indacaterol—Nervous system disorder—Doxorubicin—uterine cancer	0.000371	0.00168	CcSEcCtD
Indacaterol—Tachycardia—Doxorubicin—uterine cancer	0.000369	0.00167	CcSEcCtD
Indacaterol—Skin disorder—Doxorubicin—uterine cancer	0.000367	0.00166	CcSEcCtD
Indacaterol—Paraesthesia—Epirubicin—uterine cancer	0.000367	0.00166	CcSEcCtD
Indacaterol—Dyspnoea—Epirubicin—uterine cancer	0.000364	0.00165	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000353	0.00159	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000345	0.00156	CcSEcCtD
Indacaterol—Paraesthesia—Doxorubicin—uterine cancer	0.00034	0.00153	CcSEcCtD
Indacaterol—Dyspnoea—Doxorubicin—uterine cancer	0.000337	0.00152	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000327	0.00147	CcSEcCtD
Indacaterol—Hypersensitivity—Epirubicin—uterine cancer	0.000301	0.00136	CcSEcCtD
Indacaterol—Pruritus—Epirubicin—uterine cancer	0.000289	0.00131	CcSEcCtD
Indacaterol—Hypersensitivity—Doxorubicin—uterine cancer	0.000279	0.00126	CcSEcCtD
Indacaterol—Dizziness—Epirubicin—uterine cancer	0.00027	0.00122	CcSEcCtD
Indacaterol—Pruritus—Doxorubicin—uterine cancer	0.000268	0.00121	CcSEcCtD
Indacaterol—Rash—Epirubicin—uterine cancer	0.000258	0.00116	CcSEcCtD
Indacaterol—Dermatitis—Epirubicin—uterine cancer	0.000257	0.00116	CcSEcCtD
Indacaterol—Headache—Epirubicin—uterine cancer	0.000256	0.00116	CcSEcCtD
Indacaterol—Dizziness—Doxorubicin—uterine cancer	0.00025	0.00113	CcSEcCtD
Indacaterol—Nausea—Epirubicin—uterine cancer	0.000243	0.0011	CcSEcCtD
Indacaterol—Rash—Doxorubicin—uterine cancer	0.000238	0.00108	CcSEcCtD
Indacaterol—Dermatitis—Doxorubicin—uterine cancer	0.000238	0.00108	CcSEcCtD
Indacaterol—Headache—Doxorubicin—uterine cancer	0.000237	0.00107	CcSEcCtD
Indacaterol—Nausea—Doxorubicin—uterine cancer	0.000225	0.00101	CcSEcCtD
